Hauel Norbert | Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
スポンサーリンク
概要
- 同名の論文著者
- Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germanyの論文著者
関連著者
-
Clemens Andreas
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
Hauel Norbert
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
Wienen Wolfgang
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
van Ryn
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim, Germany
-
HAUEL Norbert
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim
-
VAN RYN
Department Cardiometabolic Disease Research, Medicinal Chemistry, Pulmonary Research and Medicine. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and Ingelheim
著作論文
- Dabigatran Etexilate : Pharmacology of the New, Oral Direct Thrombin Inhibitor
- Dabigatran Etexilate : Pharmacology of the New, Oral Direct Thrombin Inhibitor